Literature DB >> 30529040

HMGB1 and repair: focus on the heart.

Laura Pellegrini1, Eleonora Foglio2, Elena Pontemezzo2, Antonia Germani3, Matteo Antonio Russo4, Federica Limana5.   

Abstract

High-mobility group box 1 (HMGB1) is one of the most abundant proteins in eukaryotes and the best characterized damage-associated molecular pattern (DAMP). The biological activities of HMGB1 depend on its subcellular location, context and post-translational modifications. Inside the nucleus, HMGB1 is engaged in many DNA events such as DNA repair, transcription regulation and genome stability; in the cytoplasm, its main function is to regulate the autophagic flux while in the extracellular environment, it possesses more complicated functions and it is involved in a large variety of different processes such as inflammation, migration, invasion, proliferation, differentiation and tissue regeneration. Due to this pleiotropy, the role of HMGB1 has been vastly investigated in various pathological diseases and a large number of studies have explored its function in cardiovascular pathologies. However, in this contest, the precise mechanism of action of HMGB1 and its therapeutic potential are still very controversial since is debated whether HMGB1 is involved in tissue damage or plays a role in tissue repair and regeneration. The main focus of this review is to provide an overview of the effects of HMGB1 in different ischemic heart diseases and to discuss its functions in these pathological conditions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DAMPs; HMGB1; HMGB1 and heart repair; PAMPs; alarmins; molecular and cellular rehabilitation

Mesh:

Substances:

Year:  2018        PMID: 30529040     DOI: 10.1016/j.pharmthera.2018.12.005

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  19 in total

1.  HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis.

Authors:  Maria Bucova; Beata Majernikova; Vladimira Durmanova; Daniela Cudrakova; Karin Gmitterova; Iveta Lisa; Eleonora Klimova; Kristina Kluckova; Milan Buc
Journal:  Neurol Sci       Date:  2019-11-14       Impact factor: 3.307

2.  High mobility group box 1 and homocysteine as preprocedural predictors for contrast-induced acute kidney injury after percutaneous coronary artery intervention.

Authors:  Changhua Mo; Xiao Ma; Wen Jian; Qili Huang; Wenbo Zheng; Zhijie Yang; Yutao Xu; Chun Gui
Journal:  Int Urol Nephrol       Date:  2021-11-02       Impact factor: 2.370

3.  [Dihydromyricetin improves cardiac insufficiency by inhibiting HMGB1 in diabetic rats].

Authors:  S Liu; Q Liu; Q Peng; Y Zhang; J Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

4.  Recombinant High-Mobility Group Box 1 (rHMGB1) Promotes NRF2-Independent Mitochondrial Fusion through CXCR4/PSMB5-Mediated Drp1 Degradation in Endothelial Cells.

Authors:  Shunrong Zhang; Fei Feng; Jingting Dai; Jia Li; Xiangye Bu; Xiaojie Xie
Journal:  Oxid Med Cell Longev       Date:  2021-08-02       Impact factor: 6.543

5.  HMGB1-Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice.

Authors:  Xin-Lin Zhang; Ting-Yu Wang; Zheng Chen; Hong-Wei Wang; Yong Yin; Lian Wang; Yong Wang; Biao Xu; Wei Xu
Journal:  J Am Heart Assoc       Date:  2022-02-12       Impact factor: 6.106

6.  PDGFR-β signaling mediates HMGB1 release in mechanically stressed vascular smooth muscle cells.

Authors:  Ji On Kim; Seung Eun Baek; Eun Yeong Jeon; Jong Min Choi; Eun Jeong Jang; Chi Dae Kim
Journal:  PLoS One       Date:  2022-03-16       Impact factor: 3.240

7.  TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis.

Authors:  Fang-Yuan Liu; Di Fan; Zheng Yang; Nan Tang; Zhen Guo; Shu-Qing Ma; Zhen-Guo Ma; Hai-Ming Wu; Wei Deng; Qi-Zhu Tang
Journal:  Cell Death Dis       Date:  2019-06-17       Impact factor: 8.469

Review 8.  MyD88: At the heart of inflammatory signaling and cardiovascular disease.

Authors:  Abraham L Bayer; Pilar Alcaide
Journal:  J Mol Cell Cardiol       Date:  2021-08-08       Impact factor: 5.000

9.  Genome-Wide Screen and Validation of Microglia Pro-Inflammatory Mediators in Stroke.

Authors:  Jianhua Wu; Zhuoze Wu; Aodi He; Tongmei Zhang; Ping Zhang; Jing Jin; Sisi Li; Gaigai Li; Xinyan Li; Shiqi Liang; Lei Pei; Rong Liu; Qing Tian; Ximiao He; Youming Lu; Zhouping Tang; Hao Li
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

Review 10.  HMGB1-mediated apoptosis and autophagy in ischemic heart diseases.

Authors:  Eleonora Foglio; Laura Pellegrini; Antonia Germani; Matteo Antonio Russo; Federica Limana
Journal:  Vasc Biol       Date:  2019-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.